Nanomedicine and cancer immunotherapy

Authors: Hai-jun Yu1, Bruno G De Geest2
1 State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2 Department of Pharmaceutics, Ghent University, Ghent, Belgium
Correspondence to: Hai-jun Yu: hjyu@simm.ac.cn, Bruno G De Geest: br.degeest@ugent.be,
DOI: 10.1038/s41401-020-0426-2
Received: 17 April 2020
Accepted: 20 April 2020
Advance online: 28 May 2020


This special issue “Nanomedicine and Cancer Immunotherapy” was organized for the celebration of the 40th anniversary (1980–2020) of Acta Pharmacologica Sinica (APS). The prime aim for the special issue is to deliver both high-impact review and research articles to the wide international readership regarding the most recent progress in nano-immunotherapy as well as the approaches for enhancing the efficacy of cancer immunotherapy.

Article Options

Download Citation

Cited times in Scopus